ESMO Updates the Guidelines for the Diagnosis of *RET*-Altered Cancer to Herald a New Era in Targeted Therapy
The *RET* gene encodes a tyrosine kinase receptor that regulates cell survival and proliferation by triggering key downstream pathways.^1^ *RET* gene mutations and *RET* gene fusions are involved in the pathogenesis of lung, thyroid and other cancers. Recently, in 2021, the European Society for Medi...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2021-06-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/hbT.OH.2021.08.037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|